[Facioscapuloperoneal muscular dystrophy: correlation between a phenotype and genotype].

Area of Science:

• Genetics and Molecular Biology
• Neuromuscular Disorders

Context:

• Autosomal dominant facioscapuloperoneal muscular dystrophy (FSPMD) is a genetic disorder affecting muscle function.
• The 4q35 region of chromosome 4 is implicated in FSPMD, with DNA fragment size (DFS) variations observed.
• The probe p13E-11 and enzymes EcoRI/BlnI are used to detect DFS associated with FSPMD.

Purpose:

• To investigate the relationship between DFS detected by probe p13E-11 and the clinical presentation of FSPMD.
• To assess the diagnostic utility of DFS for FSPMD and its genetic heterogeneity.

Summary:

• This study analyzed DFS in symptomatic and presymptomatic FSPMD patients, identifying DFS ranging from 13-45 kb linked to chromosome 4q35.
• No significant correlation was found between DFS and FSPMD phenotype, disease severity, age at onset, or daily life disability.
• While the probe p13E-11 is confirmed for detecting FSPMD-associated DFS, the observed variations do not support genetic heterogeneity of FSHD.

Impact:

• The findings confirm the utility of probe p13E-11 for FSPMD diagnosis, particularly for DFS between 13-35 kb (or 37 kb).
• The study suggests that FSPMD and FSHD might be allelic diseases, highlighting the complexity of FSPMD genetics.
• This research contributes to understanding the genetic basis of FSPMD and aids in diagnostic approaches.